Epinephrine Market to 2027

Epinephrine Market  Epinephrine Market to 2027 - Global Analysis and Forecasts By Product Type (Prefilled Syringes, Auto-Injectors, Ampoules and Vials); Application (Anaphylaxis, Superficial Bleeding, Respiratory Disorders, Cardiac Arrest); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); and Geography

 According to our new market research study on “Epinephrine Market to 2028 – Global Analysis and Forecast – by Type, Treatment, and End User,” the market was valued at US$ 2,247.87 million in 2018 and it is projected to reach US$ 4,207.88 million by 2027; it is expected to grow at a CAGR of 8.3% from 2019 to 2027.  The global epinephrine market, based on the type, is segmented into auto-injectors, prefilled syringes and ampoules & vials. The auto-injectors segment led the epinephrine market in 2019, and; it is expected to retain its dominance during the forecast period. Key factors that are driving growth of the market are increasing anaphylaxis cases and introduction of generic version of epinephrine. However, lack of availability of epinephrine auto injectors and their low-cost alternatives is likely to have a negative impact on the growth of the market in the coming years. Epinephrine Market

Market Segments Epinephrine Market By Product Type Prefilled Syringes Auto-Injectors Ampoules and Vials By Distribution Channel Retail Pharmacies Hospital Pharmacies Online Pharmacies By Application Anaphylaxis Superficial Bleeding Respiratory Disorders Cardiac Arrest

Leading Players Epinephrine Market Company Profiles in Epinephrine Market are: MYLAN N.V. Abbott ALK ABELLO Amneal Pharma Kaleo LINCOLN MEDICAL LTD (BioProject) Teva Pharmaceuticals Ltd Adamis Pharmaceuticals Corporation (Novartis AG) Emirade Aurum Pharma

Thank You! Epinephrine Market Access Full Research Report at: https://www.theinsightpartners.com/reports/epinephrine-market Thank You!